1. Adashek JJ, LoRusso PM, Hong DS, Kurzrock R (2019) Phase I trials as valid therapeutic options for patients with cancer. Nat Rev Clin Oncol 16(12):773–778. https://doi.org/10.1038/s41571-019-0262-9
2. EMEA/CHMP (2007) Guideline on strategies to identify and mitigate risks for fist-in-human clinical trials with investigational medicinal products
3. EMEA/CHMP (2018) Guideline on strategies to identify and mitigate risks for fist-in-human clinical trials with investigational medicinal products
4. FDA (2005) Guidance for industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers
5. ICH (2010) ICH guideline S9 on nonclinical evaluation for anticancer pharmaceuticals